Biotechnology
Excalipoint Therapeutics
Excalipoint Therapeutics is tracked for AI work in Biotechnology, based in China. Shown below: 1 funding round.
Ecosystem
Not profitable
Featured: —
CN
CN
- Raised
- $68.70M
- Rounds
- 1
Figures and classifications reflect imported catalog records, not live company reporting.
Funding rounds
1 round
-
Seed Announced 18 Mar 2026$68.70M Raised $68.70M Round 6 investors Announced
Source rankings
Imported positions; not an independent quality score.
- Overall Rank#1074
- Rank#73